NCT06703450View on ClinicalTrials.gov

Guerbet Liver Fibrosis

Enrolling by invitationOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

February 28, 2024

Primary Completion Date

February 28, 2026

Study Completion Date

February 28, 2026

Conditions
Metabolic Dysfunction-associated Steatotic Liver Disease
Trial Locations (1)

10029

Mount Sinai, New York

Sponsors

Collaborators (1)

Guerbet
All Listed Sponsors
collaborator

Guerbet

INDUSTRY

lead

Icahn School of Medicine at Mount Sinai

OTHER

NCT06703450 - Guerbet Liver Fibrosis | Biotech Hunter | Biotech Hunter